[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336020-105":59,"doc-detail-336020-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","preliminary-exploration-of-the-potential-biological-functions-and-prognosis-values-of-rab4b-in-pan-cancer-combing-with-experimental-validation-in-blca","Preliminary exploration of the potential biological functions and prognosis values of RAB4B in pan-cancer combing with experimental validation in BLCA","","Preliminary exploration assesses the biological functions and prognostic value of Ras-related protein Rab-4B (RAB4B) across pan-cancers, integrating computational pan-cancer database mining with experimental validation in BLCA. RAB4B expression differences are evaluated between tumors and normal tissues, and associations are analyzed with overall survival, disease-specific survival, progression-free interval, and clinical features. Correlations with tumor mutational burden, microsatellite instability, and tumor microenvironment are assessed, alongside TIDE-based links to immune checkpoint blockade efficacy and enrichment of immune-cell pathways in most cancers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/preliminary-exploration-of-the-potential-biological-functions-and-prognosis-values-of-rab4b-in-pan-cancer-combing-with-experimental-validation-in-blca/336020/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/preliminary-exploration-of-the-potential-biological-functions-and-prognosis-values-of-rab4b-in-pan-cancer-combing-with-experimental-validation-in-blca/336020.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What biological functions and prognostic value of RAB4B are investigated in this study?","Question",{"text":112,"@type":113},"The study evaluates RAB4B’s biological functions and its prognostic value across pan-cancers, including how expression relates to survival outcomes and clinical characteristics.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were survival and clinical associations analyzed?",{"text":117,"@type":113},"RAB4B expression was used as a parameter to analyze relationships with overall survival (OS), disease-specific survival (DSS), progression-free interval (PFI), and clinical characteristics.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the study assess whether RAB4B can predict immunotherapy response?",{"text":121,"@type":113},"It analyzes correlations with tumor mutational burden (TMB), microsatellite instability (MSI), tumor microenvironment (TME), applies the TIDE algorithm for immune checkpoint blockade efficacy, and performs immune-related gene and pathway analysis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336020,1790508291,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Preliminary exploration of the potential biological functions and prognosis values of RAB4B in pan-cancer combing with experimental validation in BLCA  \nKezhen Li\\#^, Shengsheng Liang\\#, Hua Mi  \nDepartment of Urology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China  \nContributions: (I) Conception and design: K Li, S Liang; (II) Administrative support: H Mi; (III) Provision of study materials or patients: K Li, H Mi;  \n(IV) Collection and assembly of data: K Li, S Liang; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.  \n\\#These authors contributed equally to this work.  \nCorrespondence to: Hua Mi, PhD. Department of Urology, The First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Road, Nanning  \n530021, [China. Email: mihua2019@163.com](China. Email: mihua2019@163.com).  \nBackground: Ras-related protein Rab-4B (RAB4B), a small GTPase in the RAS superfamily, is involved in glucose homeostasis, synaptic homeostasis, adaptive immunity, and other processes. RAB4B has also been implicated in tumorigenesis, and its dysregulation has been linked to cancer in multiple organs. However, the potential role of RAB4B in human pan-cancers remains unknown, and whether RAB4B is a predictive  \nbiomarker for cancer immunotherapy is yet to be explored.  \nMethods: In order to investigate the potential for RAB4B as a therapeutic agent in human pan-cancersand its predictive properties, firstly, relevant data were downloaded from pan-cancers databases. Using the RAB4B expression as a parameter, an analysis was performed. The next step was to investigate how RAB4B relates to overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI) .  \nMoreover, we performed an analysis of the relationship between RAB4B and tumor mutational burden (TMB), microsatellite instability (MSI), and tumor microenvironment (TME) . Besides, the tumor immune dysfunction and exclusion (TIDE) algorithm was applied to evaluate the efficacy of RAB4B as a potential biomarker for cancer immunotherapy. A final analysis was performed on RAB4B in relation to immune  \nrelated genes and pathways.  \nResults: Results reflected that RAB4B expression was different between tumors and normal tissues. RAB4B not only positively or negatively correlated with survival indicators, but also with clinical characteristics.  \nIn addition, RAB4B positively or negatively correlated with TMB, MSI, and TME. The TIDE algorithm revealed that RAB4B was positively or negatively associated with immune checkpoint blockade. The outcome of gene set enrichment analysis (GSEA) suggested that RAB4B positively regulated biological processes and  \nimmune cell-related pathways in most cancers.  \nConclusions: According to the research results, we come to the conclusion that RAB4B as a biomarker for  \ntumor immunotherapy, RAB4B facilitates the prediction of pan-cancers prognosis.  \nKeywords: Ras-related protein Rab-4B (RAB4B); pan-cancer; biomarker; immunotherapy; prognosis  \nSubmitted Oct 07, 2023. Accepted for publication Jan 08, 2024. Published online Feb 28, 2024.  \ndoi: 10.21037/tcr-23-1840  \nView this article at: [https://dx.doi.org/10.21037/tcr-23-1840](https://dx.doi.org/10.21037/tcr-23-1840)  \n^ ORCID: 0009-0004-7816-6155.  \n© Translational Cancer Research. All rights reserved. Transl Cancer Res 2024;13(2):613-633 | [https://dx.doi.org/10.21037/tcr-23-1840](https://dx.doi.org/10.21037/tcr-23-1840)  \n614 Li et al. The values of RAB4B in pan-cancer  \nIntroduction  \nIn most countries, cancer is predicted to overtake cardiovascular disease in the 21st century, posing a serious obstacle to increasing life expectancy (1) . Although surgery, chemotherapy, and radiotherapy are the most recommended conventional cancer treatment strategies, they are associated with adverse effects, which impact the quality of patients’ life. Therefore, there is still much r","cbCaipLG7IClhphH","https://ap.wps.com/l/cbCaipLG7IClhphH","pdf",10539695,21,"English","# Introduction\n## Background and rationale\n# Methods\n## Data download and expression-based analyses\n## Survival and clinical correlation analysis\n## TMB/MSI/TME and TIDE evaluation\n# Results\n## Expression differences and survival associations\n## Links to TMB/MSI/TME and immunotherapy response\n## GSEA immune-related pathway enrichment\n# Conclusions","[{\"question\":\"What biological functions and prognostic value of RAB4B are investigated in this study?\",\"answer\":\"The study evaluates RAB4B’s biological functions and its prognostic value across pan-cancers, including how expression relates to survival outcomes and clinical characteristics.\"},{\"question\":\"How were survival and clinical associations analyzed?\",\"answer\":\"RAB4B expression was used as a parameter to analyze relationships with overall survival (OS), disease-specific survival (DSS), progression-free interval (PFI), and clinical characteristics.\"},{\"question\":\"How does the study assess whether RAB4B can predict immunotherapy response?\",\"answer\":\"It analyzes correlations with tumor mutational burden (TMB), microsatellite instability (MSI), tumor microenvironment (TME), applies the TIDE algorithm for immune checkpoint blockade efficacy, and performs immune-related gene and pathway analysis.\"}]","Preliminary exploration of the potential biological functions and prognosis values of RAB4B in pan-cancer combing with experimental validation in BLCA | PDF",1790013210,53]